The environmental impact of pharmaceuticals is becoming increasingly difficult to ignore. From manufacturing to disposal, drug residues are contributing to ecosystem damage, antimicrobial resistance (AMR), and long-term public health risks. At the same time, regulatory expectations and sustainability commitments are pushing organizations to rethink how medicines are developed, used, and managed across their lifecycle. 

EcoPharmacovigilance offers a structured approach to address this challenge by embedding sustainability across the pharmaceutical value chain. This Point of View (PoV) outlines how integrating upstream design, optimized clinical use, and downstream waste management, supported by robust monitoring and KPIs, can drive more sustainable outcomes.

Read the full PoV to understand how organizations can reduce environmental impact while improving efficiency, compliance, and long-term value creation.